TipRanks
Epsilon Healthcare Limited (DE:9TH0)
FRANKFURT:9TH0
Germany Market

Epsilon Healthcare Limited (9TH0) Ratios

0 Followers

Epsilon Healthcare Limited Ratios

DE:9TH0's free cash flow for Q2 2026 was AU$0.13. For the 2026 fiscal year, DE:9TH0's free cash flow was decreased by AU$ and operating cash flow was AU$-0.16. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Jun 25Dec 24Dec 22
Liquidity Ratios
Current Ratio
0.82 1.14 0.32 0.33 0.60
Quick Ratio
0.59 0.88 0.27 0.33 0.60
Cash Ratio
0.22 0.05 0.14 0.05 0.11
Solvency Ratio
0.08 -0.06 -0.04 0.06 -1.02
Operating Cash Flow Ratio
0.19 -0.68 -0.30 -0.11 -0.32
Short-Term Operating Cash Flow Coverage
1.01 -17.76 -0.43 -0.21 -1.01
Net Current Asset Value
AU$ -10.76MAU$ -10.68MAU$ -7.88MAU$ -4.78MAU$ -6.47M
Leverage Ratios
Debt-to-Assets Ratio
0.45 0.58 0.35 0.24 0.16
Debt-to-Equity Ratio
2.24 5.41 0.74 0.46 0.35
Debt-to-Capital Ratio
0.69 0.84 0.42 0.31 0.26
Long-Term Debt-to-Capital Ratio
0.41 0.71 0.00 0.00 0.00
Financial Leverage Ratio
5.02 9.34 2.08 1.91 2.21
Debt Service Coverage Ratio
-0.31 -0.62 -0.50 0.24 -2.78
Interest Coverage Ratio
-1.31 -1.89 -3.64 -4.69 -5.89
Debt to Market Cap
0.35 0.39 0.88 0.45 0.40
Interest Debt Per Share
0.03 0.03 0.02 0.01 0.02
Net Debt to EBITDA
-10.67 -5.44 -2.96 -2.37 -0.22
Profitability Margins
Gross Profit Margin
33.98%22.28%74.52%72.34%-43.50%
EBIT Margin
-8.96%-23.61%-87.20%-42.54%-178.72%
EBITDA Margin
-3.41%-19.79%-38.09%-19.73%-152.63%
Operating Profit Margin
-7.11%-25.31%-74.77%-36.32%-112.26%
Pretax Profit Margin
0.34%-23.90%-99.52%-49.71%-186.84%
Net Profit Margin
0.47%-13.61%-57.97%-16.40%-186.84%
Continuous Operations Profit Margin
0.47%-13.61%-57.97%-16.40%-186.84%
Net Income Per EBT
139.58%56.94%58.25%32.99%100.00%
EBT Per EBIT
-4.78%94.44%133.11%136.87%166.44%
Return on Assets (ROA)
0.50%-7.16%-14.58%-7.57%-64.82%
Return on Equity (ROE)
3.34%-66.86%-30.35%-14.47%-143.35%
Return on Capital Employed (ROCE)
-10.65%-17.94%-38.92%-30.04%-63.53%
Return on Invested Capital (ROIC)
-9.85%-9.80%-22.46%-6.95%-52.81%
Return on Tangible Assets
0.50%-7.16%-14.58%-7.60%-64.82%
Earnings Yield
0.89%-10.20%-36.25%-15.00%-210.62%
Efficiency Ratios
Receivables Turnover
9.81 2.59 5.13 5.25 2.26
Payables Turnover
3.37 2.24 0.55 1.53 2.35
Inventory Turnover
9.78 6.06 2.70 0.00 0.00
Fixed Asset Turnover
1.43 0.77 0.30 0.55 0.46
Asset Turnover
1.05 0.53 0.25 0.46 0.35
Working Capital Turnover Ratio
-19.47 -2.62 -0.93 -1.79 -5.71
Cash Conversion Cycle
-33.82 38.27 -456.15 -169.06 6.41
Days of Sales Outstanding
37.22 140.94 71.17 69.47 161.40
Days of Inventory Outstanding
37.34 60.21 135.30 0.00 0.00
Days of Payables Outstanding
108.37 162.89 662.62 238.53 154.99
Operating Cycle
74.55 201.16 206.47 69.47 161.40
Cash Flow Ratios
Operating Cash Flow Per Share
<0.01 >-0.01 >-0.01 >-0.01 -0.01
Free Cash Flow Per Share
<0.01 >-0.01 >-0.01 >-0.01 -0.01
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
0.87 1.05 1.03 1.14 1.21
Dividend Paid and CapEx Coverage Ratio
7.95 -18.42 -34.85 -7.03 -4.86
Capital Expenditure Coverage Ratio
7.95 -18.42 -34.85 -7.03 -4.86
Operating Cash Flow Coverage Ratio
0.13 -0.30 -0.43 -0.20 -0.80
Operating Cash Flow to Sales Ratio
0.05 -0.33 -0.61 -0.11 -0.36
Free Cash Flow Yield
8.96%-26.30%-39.12%-11.05%-49.13%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
93.33 -9.71 -2.76 -6.67 -0.47
Price-to-Sales (P/S) Ratio
0.53 1.33 1.60 1.09 0.89
Price-to-Book (P/B) Ratio
2.81 6.55 0.84 0.96 0.68
Price-to-Free Cash Flow (P/FCF) Ratio
11.17 -3.80 -2.56 -9.05 -2.04
Price-to-Operating Cash Flow Ratio
9.76 -4.01 -2.63 -10.34 -2.45
Price-to-Earnings Growth (PEG) Ratio
0.23 0.16 -0.02 0.07 -0.03
Price-to-Fair Value
2.81 6.55 0.84 0.96 0.68
Enterprise Value Multiple
-26.36 -12.18 -7.16 -7.91 -0.80
Enterprise Value
18.30M 22.64M 15.27M 10.38M 8.65M
EV to EBITDA
-26.36 -12.18 -7.16 -7.91 -0.80
EV to Sales
0.90 2.41 2.73 1.56 1.22
EV to Free Cash Flow
18.75 -6.87 -4.36 -12.92 -2.79
EV to Operating Cash Flow
16.40 -7.24 -4.49 -14.76 -3.36
Tangible Book Value Per Share
<0.01 <0.01 0.03 0.02 0.04
Shareholders’ Equity Per Share
<0.01 <0.01 0.03 0.02 0.04
Tax and Other Ratios
Effective Tax Rate
-0.13 0.43 -0.42 0.67 0.00
Revenue Per Share
0.05 0.02 0.02 0.02 0.03
Net Income Per Share
<0.01 >-0.01 >-0.01 >-0.01 -0.05
Tax Burden
1.40 0.57 0.58 0.33 1.00
Interest Burden
-0.04 1.01 1.14 1.17 1.05
Research & Development to Revenue
0.00 0.00 0.00 <0.01 0.05
SG&A to Revenue
0.40 0.52 0.81 0.43 0.55
Stock-Based Compensation to Revenue
0.02 0.00 0.00 0.00 0.00
Income Quality
-1.65 1.52 1.05 0.64 0.19
Currency in AUD